Header Logo

Connection

Pankaj Singh to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications Pankaj Singh has written about Cell Line, Tumor.
Pankaj Singh
Connection Strength
2.882
Cell Line, Tumor
  1. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 2024 Jul 08; 12.
    View in: PubMed
    Score: 0.164
  2. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
    View in: PubMed
    Score: 0.133
  3. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Cancer Lett. 2020 10 28; 491:70-77.
    View in: PubMed
    Score: 0.124
  4. SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. 2020 07 06; 217(7).
    View in: PubMed
    Score: 0.124
  5. MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism. Oncogene. 2020 04; 39(16):3381-3395.
    View in: PubMed
    Score: 0.121
  6. Evaluating the Metabolic Alterations in Pancreatic Cancer. Methods Mol Biol. 2019; 1882:221-228.
    View in: PubMed
    Score: 0.112
  7. Molecular and Physiological Evaluation of Pancreatic Cancer-Induced Cachexia. Methods Mol Biol. 2019; 1882:321-333.
    View in: PubMed
    Score: 0.112
  8. Evaluating the Metabolic Impact of Hypoxia on Pancreatic Cancer Cells. Methods Mol Biol. 2018; 1742:81-93.
    View in: PubMed
    Score: 0.104
  9. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells. Methods Mol Biol. 2018; 1742:95-105.
    View in: PubMed
    Score: 0.104
  10. Hypoxia-Mediated In Vivo Tumor Glucose Uptake Measurement and Analysis. Methods Mol Biol. 2018; 1742:107-113.
    View in: PubMed
    Score: 0.104
  11. Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia. Methods Mol Biol. 2018; 1742:265-276.
    View in: PubMed
    Score: 0.104
  12. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Cancer Res. 2017 10 15; 77(20):5503-5517.
    View in: PubMed
    Score: 0.101
  13. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clin Cancer Res. 2017 Oct 01; 23(19):5881-5891.
    View in: PubMed
    Score: 0.101
  14. MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer. PLoS One. 2017; 12(5):e0176820.
    View in: PubMed
    Score: 0.099
  15. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Cancer Lett. 2017 08 01; 400:37-46.
    View in: PubMed
    Score: 0.099
  16. Validation of Metabolic Alterations in Microscale Cell Culture Lysates Using Hydrophilic Interaction Liquid Chromatography (HILIC)-Tandem Mass Spectrometry-Based Metabolomics. PLoS One. 2016; 11(4):e0154416.
    View in: PubMed
    Score: 0.093
  17. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. 2015 Dec 01; 6(38):41146-61.
    View in: PubMed
    Score: 0.090
  18. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget. 2015 Aug 07; 6(22):19118-31.
    View in: PubMed
    Score: 0.088
  19. Podophyllum hexandrum fraction (REC-2006) shows higher radioprotective efficacy in the p53-carrying hepatoma cell line: a role of cell cycle regulatory proteins. Integr Cancer Ther. 2009 Sep; 8(3):261-72.
    View in: PubMed
    Score: 0.058
  20. Pifithrin-alpha decreases the radioprotective efficacy of a Podophyllum hexandrum Himalayan mayapple fraction REC-2006 in HepG2 cells. Biotechnol Appl Biochem. 2009 Jul 09; 54(1):53-64.
    View in: PubMed
    Score: 0.058
  21. Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression. J Biol Chem. 2008 Oct 03; 283(40):26985-95.
    View in: PubMed
    Score: 0.054
  22. Platelet-derived growth factor receptor beta-mediated phosphorylation of MUC1 enhances invasiveness in pancreatic adenocarcinoma cells. Cancer Res. 2007 Jun 01; 67(11):5201-10.
    View in: PubMed
    Score: 0.050
  23. Adaptation to cystine limitation stress confers a targetable lipid metabolism vulnerability in pancreatic ductal adenocarcinoma. Nat Commun. 2025 Dec 31; 17(1):1343.
    View in: PubMed
    Score: 0.045
  24. A Fluorescence Resonance Energy Transfer-Based Assay Targeting Tumor-Derived Extracellular Vesicles for Highly Specific Pancreatic Cancer Detection. ACS Nano. 2025 Dec 23; 19(50):42056-42065.
    View in: PubMed
    Score: 0.045
  25. Targeting the Glucose-Insulin Link in Head and Neck Squamous Cell Carcinoma Induces Cytotoxic Oxidative Stress and Inhibits Cancer Growth. Cancer Res Commun. 2025 Jun 01; 5(6):921-938.
    View in: PubMed
    Score: 0.044
  26. MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer. Oncogene. 2022 07; 41(31):3859-3875.
    View in: PubMed
    Score: 0.036
  27. Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer. Cancer Res. 2022 06 15; 82(12):2254-2268.
    View in: PubMed
    Score: 0.035
  28. Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression. Cancer Lett. 2021 10 10; 518:230-242.
    View in: PubMed
    Score: 0.033
  29. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Lett. 2020 08 01; 484:29-39.
    View in: PubMed
    Score: 0.031
  30. The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma. EMBO Mol Med. 2019 12; 11(12):e10849.
    View in: PubMed
    Score: 0.029
  31. Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments. Cell Rep. 2019 09 10; 28(11):2824-2836.e8.
    View in: PubMed
    Score: 0.029
  32. Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors. J Control Release. 2019 07 28; 306:149-164.
    View in: PubMed
    Score: 0.029
  33. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019 04; 25(4):628-640.
    View in: PubMed
    Score: 0.028
  34. RNA-Binding Protein HuR Regulates Both Mutant and Wild-Type IDH1 in IDH1-Mutated Cancer. Mol Cancer Res. 2019 02; 17(2):508-520.
    View in: PubMed
    Score: 0.027
  35. Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. J Proteome Res. 2017 10 06; 16(10):3536-3546.
    View in: PubMed
    Score: 0.025
  36. Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer Cells. Mol Cancer Ther. 2017 09; 16(9):1819-1830.
    View in: PubMed
    Score: 0.025
  37. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat Commun. 2017 05 26; 8:15503.
    View in: PubMed
    Score: 0.025
  38. Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer. Br J Pharmacol. 2016 Dec; 173(23):3292-3306.
    View in: PubMed
    Score: 0.024
  39. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. Biomacromolecules. 2016 Jan 11; 17(1):301-13.
    View in: PubMed
    Score: 0.023
  40. Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3. Oncotarget. 2015 Nov 03; 6(34):36019-31.
    View in: PubMed
    Score: 0.022
  41. Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer. Biochemistry. 2014 Mar 04; 53(8):1360-72.
    View in: PubMed
    Score: 0.020
  42. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects. Int Immunopharmacol. 2013 May; 16(1):72-8.
    View in: PubMed
    Score: 0.019
  43. Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism. Cancer Lett. 2012 Oct 01; 323(1):29-40.
    View in: PubMed
    Score: 0.017
  44. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Clin Cancer Res. 2011 Oct 01; 17(19):6140-50.
    View in: PubMed
    Score: 0.017
  45. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene. 2010 Oct 21; 29(42):5667-77.
    View in: PubMed
    Score: 0.016
  46. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res. 2008 Oct 01; 14(19):5995-6004.
    View in: PubMed
    Score: 0.014
  47. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Res. 2008 Apr 01; 68(7):2065-70.
    View in: PubMed
    Score: 0.013
  48. MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion. Cancer Res. 2007 Nov 01; 67(21):10222-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.